Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 94,694 | 59,120 | 41,848 | 43,735 | 18,170 |
Gross Profit | 94,694 | 59,120 | 41,848 | 43,735 | 18,170 |
Operating Expenses | 41,271 | 38,007 | 36,943 | 29,723 | 34,469 |
Operating Income | 53,423 | 21,113 | 4,905 | 14,012 | -16,299 |
Other Income | 4,366 | 4,214 | 4,292 | 4,051 | 4,218 |
Pre-tax Income | 57,789 | 25,327 | 9,197 | 18,063 | -12,081 |
Income Tax | 2,758 | 1,831 | 18,741 | -17,398 | 13,847 |
Net Income Continuous | 55,031 | 23,496 | -9,544 | 35,461 | -25,928 |
Net Income | $55,031 | $23,496 | $-9,544 | $35,461 | $-25,928 |
EPS Basic Total Ops | 1.61 | 0.70 | -0.28 | 1.07 | -0.78 |
EPS Basic Continuous Ops | 1.61 | 0.70 | -0.28 | 1.07 | -0.78 |
EPS Diluted Total Ops | 1.55 | 0.68 | -0.23 | 1.02 | -0.78 |
EPS Diluted Continuous Ops | 1.55 | 0.68 | -0.23 | 1.02 | -0.78 |
EPS Diluted Before Non-Recurring Items | N/A | 0.68 | -0.29 | 1.02 | -0.78 |
EBITDA(a) | $52,072 | $20,010 | $3,642 | $12,994 | $-17,260 |